Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hira Lal

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Genes & Development|January 7, 2015
A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cellsCheng Chang, Hira Lal Goel, Huijie Gao, et al.
EMBO Molecular Medicine|February 26, 2013
GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiationHira Lal Goel, Bryan Pursell, Cheng Chang, et al.
Nature|October 25, 2023
Disruption of sugar nucleotide clearance is a therapeutic vulnerability of cancer cellsMihir B Doshi, Namgyu Lee, Tenzin Tseyang, et al.
Journal of Cellular Physiology|January 30, 2013
β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1Hira Lal Goel, Aejaz Sayeed, Michael Breen, et al.
The Journal of Clinical Investigation|October 1, 2024
Neuropilin-2-expressing breast cancer cells mitigate radiation-induced oxidative stress through nitric oxide signalingAyush Kumar, Hira Lal Goel, Christi A Wisniewski, et al.
Urologia Internationalis|February 23, 2012
Isolated renal zygomycosis: novel diagnostic and prognostic criteria with experience of a tertiary care centerSaurabh S Chipde, Priyadarshi Ranjan, Hira Lal, et al.
Cancer Discovery|July 11, 2012
VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancerHira Lal Goel, Cheng Chang, Bryan Pursell, et al.
Science Translational Medicine|May 3, 2023
Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancerMengdie Wang, Christi A Wisniewski, Choua Xiong, et al.
Lancet (London, England)|August 9, 2025
Post-exposure prophylaxis regimen of rabies monoclonal antibody and vaccine in category 3 potential exposure patients: a phase 4, open-label, randomised, active-controlled trialPrasad S Kulkarni, Anirudha Vyankatesh Potey, Dhananjay Kapse, et al.
Science Translational Medicine|May 3, 2023
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancerZhiwen Xu, Hira Lal Goel, Christoph Burkart, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Genes & Development|January 7, 2015
A laminin 511 matrix is regulated by TAZ and functions as the ligand for the α6Bβ1 integrin to sustain breast cancer stem cellsCheng Chang, Hira Lal Goel, Huijie Gao, et al.
EMBO Molecular Medicine|February 26, 2013
GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiationHira Lal Goel, Bryan Pursell, Cheng Chang, et al.
Nature|October 25, 2023
Disruption of sugar nucleotide clearance is a therapeutic vulnerability of cancer cellsMihir B Doshi, Namgyu Lee, Tenzin Tseyang, et al.
Journal of Cellular Physiology|January 30, 2013
β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1Hira Lal Goel, Aejaz Sayeed, Michael Breen, et al.
The Journal of Clinical Investigation|October 1, 2024
Neuropilin-2-expressing breast cancer cells mitigate radiation-induced oxidative stress through nitric oxide signalingAyush Kumar, Hira Lal Goel, Christi A Wisniewski, et al.
Urologia Internationalis|February 23, 2012
Isolated renal zygomycosis: novel diagnostic and prognostic criteria with experience of a tertiary care centerSaurabh S Chipde, Priyadarshi Ranjan, Hira Lal, et al.
Cancer Discovery|July 11, 2012
VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancerHira Lal Goel, Cheng Chang, Bryan Pursell, et al.
Science Translational Medicine|May 3, 2023
Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancerMengdie Wang, Christi A Wisniewski, Choua Xiong, et al.
Lancet (London, England)|August 9, 2025
Post-exposure prophylaxis regimen of rabies monoclonal antibody and vaccine in category 3 potential exposure patients: a phase 4, open-label, randomised, active-controlled trialPrasad S Kulkarni, Anirudha Vyankatesh Potey, Dhananjay Kapse, et al.
Science Translational Medicine|May 3, 2023
Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancerZhiwen Xu, Hira Lal Goel, Christoph Burkart, et al.
Pageof 18